Dual-Agonist Compound Promising in T2D, Obesity

(MedPage Today) -- A dual-agonist compound that aims to boost two key gut hormones -- GLP-1 and GIP -- at the same time may offer better blood sugar control and weight loss than single-hormone drugs that are currently available, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/11/dual-agonist-compound-promising-in-t2d.html